XENO (Xeno Transplants) Notes Receivable: $0.00 Mil (As of Mar. 2008)


What is Xeno Transplants Notes Receivable?

Xeno Transplants XENO Notes Receivable is $0.00 Mil as of Mar. 2008.

Xeno Transplants's Notes Receivable for the quarter that ended in Mar. 2008 was $0.00 Mil.

Xeno Transplants Notes Receivable Related Terms

Xeno Transplants Notes Receivable Historical Data

* Premium members only.

The historical data trend for Xeno Transplants's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xeno Transplants Notes Receivable Chart

Xeno Transplants Annual Data
Trend Jun05 Jun06 Jun07
Notes Receivable
0.00 0.00 0.00

Xeno Transplants Quarterly Data
Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Xeno Transplants Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Xeno Transplants (XENO) has a Notes Receivable of $0.00 Mil as of Mar. 2008. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Xeno Transplants and its competitors.
Is Xeno Transplants' Notes Receivable too high?
Xeno Transplants' current Notes Receivable is $0.00 Mil.
How does Xeno Transplants' Notes Receivable compare to PRTX and GWSN?
Xeno Transplants' Notes Receivable of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Biotechnology company?
A good Notes Receivable depends on the Biotechnology industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Xeno Transplants and its competitors. Xeno Transplants's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xeno Transplants stock overvalued right now?
Xeno Transplants (XENO) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Xeno Transplants (XENO), the current Notes Receivable is $0.00 Mil as of Mar. 2008. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Xeno Transplants Business Description

Address 143 Gardner Road, Brookline, MA, USA, 02445
Xeno Transplants Corp is a bio-technology research and development company, which intends to develop therapeutic applications of organs and cells derived from genetically engineered pigs as a transplant alternative to limited human donor sources.